Literature DB >> 32811636

On providing smoking cessation services in alcohol and other drug treatment settings: Results from a U.S. national survey of attitudes among recovering persons.

John F Kelly1, M Claire Greene2, Lauren A Hoffman3, Bettina B Hoeppner3, Brandon G Bergman3.   

Abstract

BACKGROUND: Nicotine addiction through cigarette use is highly prevalent among individuals suffering from alcohol and other drug (AOD) problems and remains a prominent risk factor for morbidity, mortality, and healthcare utilization. Whereas most people agree that providing smoking cessation services (SCS) to this vulnerable population is vitally important, the timing of such service provision has been hotly debated, including whether such services should be excluded, available (but not offered), offered, or fully integrated into AOD treatment settings. Important stakeholders in this debate are those in recovery from AOD problems who, in addition to having often been AOD treatment patients themselves, frequently hold influential clinical, research or policy positions and thus can influence the likelihood of SCS provision. This study sought to understand the attitudes of this important stakeholder group in providing SCS in AOD treatment settings.
METHOD: We assessed a national cross-sectional sample of individuals in recovery from an AOD problem (n = 1973) on whether SCS should be: a. excluded; b. available; c. offered; or d. integrated into AOD services. We estimated associations between participants' demographic, clinical, and recovery support service use history, and SCS attitude variables, using multinomial logistic regression.
RESULTS: Roughly equal proportions endorsed each attitudinal position (23.5% excluded, 25% available, 24.6% offered; 26.9% integrated). Correlates of holding more positive SCS implementation attitudes were Black race; primary substance other than alcohol, greater intensity of former or recent smoking, and less mutual-help organization participation; older individuals achieving recovery between 30 and 40 years ago also had more positive attitudes toward integrating SCS.
CONCLUSIONS: About half of those sampled were either against SCS inclusion in AOD settings or were in favor of making it "available" only, but not in offering it or integrating it. This oppositional pattern was accentuated particularly among those with primary alcohol problem histories and those participating in mutual-help organizations. Given the universally well-known negative health effects of smoking, understanding more about the exact reasons why certain groups of recovering persons may endorse such positions is an area worthy of further investigation, as it may uncover potential barriers to SCS implementation in AOD treatment settings.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Addiction; Cigarette smoking; Epidemiology; National; Recovery; Remission; Smoking cessation services in addiction treatment; Substance use disorder treatment

Mesh:

Substances:

Year:  2020        PMID: 32811636      PMCID: PMC7556344          DOI: 10.1016/j.jsat.2020.108057

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  27 in total

1.  Smoking cessation services and smoke-free policies at substance abuse treatment facilities: national survey results.

Authors:  Yuyan Shi; Sharon E Cummins
Journal:  Psychiatr Serv       Date:  2015-02-17       Impact factor: 3.084

2.  Racially classified social group differences in cigarette smoking, nicotine dependence, and readiness to quit.

Authors:  Mary Kay Rayens; Ellen J Hahn; Anita Fernander; Chizimuzo T C Okoli
Journal:  J Addict Nurs       Date:  2013 Apr-Jun       Impact factor: 1.476

3.  The implementation of smoking cessation counseling in substance abuse treatment.

Authors:  Hannah K Knudsen; Christina R Studts; Jamie L Studts
Journal:  J Behav Health Serv Res       Date:  2012-01       Impact factor: 1.505

Review 4.  Smoking prevalence in addiction treatment: a review.

Authors:  Joseph Guydish; Emma Passalacqua; Barbara Tajima; Mable Chan; Jongserl Chun; Alan Bostrom
Journal:  Nicotine Tob Res       Date:  2011-04-04       Impact factor: 4.244

5.  Smoking abstinence-related expectancies among American Indians, African Americans, and women: potential mechanisms of tobacco-related disparities.

Authors:  Peter S Hendricks; J Lee Westmaas; Van M Ta Park; Christopher B Thorne; Sabrina B Wood; Majel R Baker; R Marsh Lawler; Monica Webb Hooper; Kevin L Delucchi; Sharon M Hall
Journal:  Psychol Addict Behav       Date:  2013-03-25

6.  Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort.

Authors:  R D Hurt; K P Offord; I T Croghan; L Gomez-Dahl; T E Kottke; R M Morse; L J Melton
Journal:  JAMA       Date:  1996-04-10       Impact factor: 56.272

7.  Prevalence and pathways of recovery from drug and alcohol problems in the United States population: Implications for practice, research, and policy.

Authors:  John F Kelly; Brandon Bergman; Bettina B Hoeppner; Corrie Vilsaint; William L White
Journal:  Drug Alcohol Depend       Date:  2017-10-18       Impact factor: 4.492

Review 8.  Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders.

Authors:  Dorie Apollonio; Rose Philipps; Lisa Bero
Journal:  Cochrane Database Syst Rev       Date:  2016-11-23

9.  Quit attempt correlates among smokers by race/ethnicity.

Authors:  Jennifer W Kahende; Ann M Malarcher; Anna Teplinskaya; Kat J Asman
Journal:  Int J Environ Res Public Health       Date:  2011-09-28       Impact factor: 3.390

Review 10.  Tobacco cessation treatment for alcohol-dependent smokers: when is the best time?

Authors:  Molly Kodl; Steven S Fu; Anne M Joseph
Journal:  Alcohol Res Health       Date:  2006
View more
  1 in total

1.  Recovery community centers: Characteristics of new attendees and longitudinal investigation of the predictors and effects of participation.

Authors:  John F Kelly; Nilofar Fallah-Sohy; Julie Cristello; Robert L Stout; Leonard A Jason; Bettina B Hoeppner
Journal:  J Subst Abuse Treat       Date:  2021-01-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.